ITAFOS INC. ON (82E) - Total Liabilities
Based on the latest financial reports, ITAFOS INC. ON (82E) has total liabilities worth €378.91 Million EUR (≈ $442.98 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 82E net assets growth trend to track the company's year-over-year net asset growth rate.
ITAFOS INC. ON - Total Liabilities Trend (2021–2025)
This chart illustrates how ITAFOS INC. ON's total liabilities have evolved over time, based on quarterly financial data. See ITAFOS INC. ON free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
ITAFOS INC. ON Competitors by Total Liabilities
The table below lists competitors of ITAFOS INC. ON ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dishman Carbogen Amcis Limited
NSE:DCAL
|
India | Rs47.44 Billion |
|
Eupraxia Pharmaceuticals Inc
TO:EPRX
|
Canada | CA$5.43 Million |
|
Guangxi Bossco Environmental Protection Technology Co Ltd
SHE:300422
|
China | CN¥7.95 Billion |
|
Shandong Sinobioway Biomedicine Co Ltd
SHE:002581
|
China | CN¥221.51 Million |
|
Seoul Semiconductor Co. Ltd
KQ:046890
|
Korea | ₩508.04 Billion |
|
Keros Therapeutics Inc
NASDAQ:KROS
|
USA | $39.20 Million |
|
Uchi Technologies Bhd
KLSE:7100
|
Malaysia | RM26.26 Million |
|
Vetropack Holding SA
SW:VETN
|
Switzerland | CHF479.00 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down ITAFOS INC. ON's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 82E market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ITAFOS INC. ON's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ITAFOS INC. ON (2021–2025)
The table below shows the annual total liabilities of ITAFOS INC. ON from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €403.00 Million ≈ $471.15 Million |
+15.79% |
| 2024-12-31 | €348.03 Million ≈ $406.89 Million |
+5.95% |
| 2023-12-31 | €328.50 Million ≈ $384.05 Million |
-8.98% |
| 2022-12-31 | €360.89 Million ≈ $421.92 Million |
-27.71% |
| 2021-12-31 | €499.25 Million ≈ $583.67 Million |
-- |
About ITAFOS INC. ON
Itafos Inc., together with its subsidiaries, produces and sells phosphate and specialty fertilizers in the United States, Brazil, and Guinea-Bissau. The company operates through three segments: Conda, Arrais, and Development and Exploration. It offers monoammonium phosphate, monoammonium phosphate with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, a… Read more